◆ TICKERBASEOpen interactive view →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY
Home › All stocks › I › IRMD

Iradimed Co (IRMD) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · MEDICAL DEVICES · DATA UPDATED 2026-09-17

Iradimed Co (IRMD) operates in the MEDICAL DEVICES industry and is headquartered in Orlando, United States with about 166 employees. Its market capitalization is roughly $1 billion. In the fiscal year ended 2025-12-31, IRMD reported $84M in revenue and $22M in net income.

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories.

Interactive charts & full statements → Open the IRMD valuation workbench →

IRMD Revenue & Earnings History — Annual Income Statement

Income statementTTM → 2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Total Revenue$86M$84M$73M$66M$53M$42M$32M$39M$30M$23M$32M$32M$16M$11M$8M
Gross Profit$66M$64M$56M$50M$41M$32M$24M$30M$23M$18M$26M$26M$12M$8M$6M
Gross Margin %75.9%76.8%76.9%76.5%77.5%76.6%74.3%77.1%76.3%75.9%81.1%81.5%78.2%74.8%72.3%
Operating Income (EBIT)$28M$26M$22M$20M$16M$10M($1M)$9M$6M$1M$11M$12M$3M$3M$1M
Operating Margin %31.9%31.2%30.0%30.6%29.3%23.5%-2.4%22.4%19.7%5.6%33.6%36.4%19.6%24.6%18.5%
Net Income$23M$22M$19M$17M$13M$9M$1M$10M$6M$0M$7M$8M$2M$2M$1M
Net Margin %26.7%26.8%26.3%26.2%24.1%22.3%4.3%25.0%20.7%2.2%22.2%23.8%13.1%17.1%12.6%
EBITDA$31M$31M$25M$20M$16M$11M$1M$10M$7M$3M$11M$12M$3M$3M$2M
Earnings Per Share (EPS)$1.79$1.75$1.50$1.35$1.02$0.74$0.11$0.78$0.52$0.04$0.60$0.60$0.20$0.19$0.09
Shares Outstanding (M)13M13M13M13M13M13M12M12M12M12M12M13M10M10M10M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

IRMD Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Total Revenue$20M$22M$23M$21M$20M$20M$19M$18M
Gross Profit$15M$17M$17M$16M$16M$15M$15M$14M
Gross Margin %74.1%76.5%75.1%77.8%78.2%76.1%76.1%77.4%
Operating Income (EBIT)$6M$7M$7M$7M$7M$5M$6M$6M
Operating Margin %31.2%32.9%31.3%32.2%33.3%27.8%29.9%31.6%
Net Income$5M$6M$6M$6M$6M$5M$5M$5M
Net Margin %25.5%26.5%28.4%26.3%28.3%24.0%26.5%27.6%
EBITDA$7M$8M$8M$8M$8M$6M$7M$7M
Earnings Per Share (EPS)$0.41$0.45$0.50$0.43$0.45$0.37$0.40$0.40
Shares Outstanding (M)13M13M13M13M13M13M13M13M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

IRMD Free Cash Flow History

Cash flowTTM → 2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Cash from Operations (CFO)$27M$25M$26M$13M$10M$11M$6M$10M$7M$3M$9M$8M$3M$1M$2M
Capital Expenditures (CapEx)$2M$8M$8M$8M$2M$1M$1M$0M$0M$1M$2M$0M$1M$0M$0M
Free Cash Flow (FCF)$25M$17M$18M$5M$8M$11M$5M$10M$7M$3M$8M$7M$2M$1M$1M
FCF Margin %28.9%20.5%24.1%8.3%15.3%25.1%16.3%25.3%23.4%11.2%24.2%23.2%12.7%11.3%17.5%
Dividends Paid$16M$15M$14M$13M$13M$13M$13M$13M—$0M$0M$0M$0M——

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

IRMD Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Cash from Operations (CFO)$6M$8M$6M$7M$8M$4M$6M$9M
Capital Expenditures (CapEx)$0M$0M$0M$1M$3M$4M$3M$4M
Free Cash Flow (FCF)$6M$8M$5M$6M$5M$1M$3M$5M
FCF Margin %28.1%35.9%24.0%27.6%24.1%3.0%15.1%27.9%
Dividends Paid$3M$3M$9M$2M$2M$2M$2M$2M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

IRMD Balance Sheet History

Balance sheet2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Total Assets$115M$109M$98M$92M$86M$83M$71M$67M$48M$39M$37M$35M$23M$7M$6M
Cash & Cash Equivalents$59M$51M$52M$50M$58M$62M$50M$43M$28M$18M$18M$19M$9M$2M$2M
Total Liabilities$13M$14M$12M$21M$12M$11M$10M$11M$6M$6M$5M$3M$2M$2M$2M
Total Debt (Short + Long-Term)$0M$0M$0M$0M$0M$0M$0M$0M$0M$2M$1M$0M$0M$0M$1M
Total Shareholders' Equity$102M$95M$87M$71M$74M$72M$61M$56M$42M$33M$32M$32M$21M$5M$3M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive IRMD viewer.

Other Companies in MEDICAL DEVICES

← IRMAll “I” companiesIRMENERGY →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.